Omeros Corporation (NASDAQ:OMER) shot up more than 60% in pre-market trading on Tuesday after the pharmaceutical company announced additional positive data for OMS721 …
In a research report released Wednesday, MLV & Co. analyst Ram Selvaraju initiated coverage on shares of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) with a Buy …
MLV’s healthcare analyst Arlinda Lee weighed in today with his views on Halozyme Therapeutics, Inc. (NASDAQ:HALO), after the company announced interim findings from the ongoing phase …
In a report that reiterated familiar growth strategies, MLV & Co. analyst Vernon Bernardino upgraded Coronado Biosciences Inc (NASDAQ:CNDO) to a Buy from a …
In a research report published after market close today, MLV & Co. analyst Vernon Bernardino initiated coverage on shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) with …
In a research note issued this morning, MLV analyst Arlinda Lee reiterated a Buy rating on Synta Pharmaceuticals Corp. (NASDAQ:SNTA) with a $6.
In a research report released Friday, MLV & Co. analyst Thomas Yip reiterated a Buy rating on Peregrine Pharmaceuticals (NASDAQ:PPHM) with a $3.
In a research report issued today after market close, MLV & Co. analyst Arlinda Lee reiterated a Buy rating on shares of Halozyme Therapeutics, Inc.
In a research report issued today, MLV & Co. analyst Carter Driscoll reiterated a Buy rating on Tesla Motors (NASDAQ:TSLA) with a price target …
MLV & Co. analyst Carter Driscoll was out today with some bullish comments on Ballard Power Systems (NASDAQ:BLDP), following this morning’s news of 2-year extension of …
